
New BIOTECH insight newsletter out
In its latest issue, the BIOTECH Insight newsletter of Deutsche Börse AG and its partner BIOCOM AG covers latest figures of a company survey that...

CEPI commits up to US$80m to University of Oxford to develop vaccines
The US$80m strategic partnership of CEPI, which was established in 2016 in the wake of the Ebola virus outbreak in west Africa, the University of...

Neuraxpharm pays US$650m for MS drug commercialisation
Together with a fee of US$12.5m for the launch of the B cell suppressant antibody to treat relapsing/remitting mulitple sclerosis (rMS), the US$140m...

Retinopathy: Golgi and Breye join forces
The two companies announced their collaboration, which aims to find treatment options for both early-stage diabetic retinopathy (DR) and dry-AMD...

Bavarian Nordic A/S bags US$120m for smallpox vaccine
Under a deal with the US agency BARDA, Bavarian Nordic A/S (Copenhagen) will cash in US$96m in 2023 ffor the manufacturing of a n new buk product of...

Resistance blocker of immune checkpoint inhibitors gets patented
DT-9081, Domain Therapeutics’ selective EP4 receptor antagonist, preclinically synergised with PD1-checkpoint blockers and shrinked tumours by...

UK invests in biopharma manufacturers
The agency announced that seventeen new projects will receive funding for cutting edge medicine manufacturing, delivered by the Innovate UK...